Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Sherry · SciRah

Researcher profile · Semantic Scholar

R. Sherry

Share profile

R. Sherry — researcher profile on SciRah

h-index: 62
Works: 129
Citations: 42K

Most-cited papers

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
R. Morgan, M. Dudley, J. Wunderlich, M. Hughes +12 more
2006Science2,746 citations Open access
Semantic Scholar
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy
S. Rosenberg, J. Yang, R. Sherry, U. Kammula +11 more
2011Clinical Cancer Research1,999 citations Open access
Semantic Scholar
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
M. Dudley, J. Wunderlich, J. Yang, R. Sherry +17 more
2005Journal of Clinical Oncology1,723 citations Open access
Semantic Scholar
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.
P. Robbins, R. Morgan, S. Feldman, J. Yang +17 more
2011Journal of Clinical Oncology1,629 citations Open access
Semantic Scholar
Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.
J. Kochenderfer, M. Dudley, Sadik H. Kassim, R. Somerville +22 more
2015Journal of Clinical Oncology1,480 citations Open access
Semantic Scholar
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.
L. Johnson, R. Morgan, M. Dudley, L. Cassard +21 more
2009Blood1,448 citations Open access
Semantic Scholar
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells.
J. Kochenderfer, M. Dudley, S. Feldman, W. Wilson +14 more
2012Blood1,410 citations Open access
Semantic Scholar
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
M. Dudley, J. Yang, R. Sherry, M. Hughes +16 more
2008Journal of Clinical Oncology1,367 citations Open access
Semantic Scholar
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
R. Royal, Catherine L. Levy, Keli M. Turner, A. Mathur +7 more
2010Journal of immunotherapy1,133 citations Open access
Semantic Scholar
Cancer regression and neurologic toxicity following anti-MAGE-A3 TCR gene therapy
R. Morgan, N. Chinnasamy, Daniel Abate-Daga, A. Gros +27 more
2013Journal of immunotherapy1,108 citations Open access
Semantic Scholar
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.
Peter Attia, G. Phan, A. Maker, M. Robinson +13 more
2005Journal of Clinical Oncology992 citations Open access
Semantic Scholar
The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
Y. Herishanu, P. Pérez-Galán, De-Long Liu, A. Biancotto +20 more
2011Blood876 citations Open access
Semantic Scholar
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis.
M. Parkhurst, J. Yang, R. Langan, M. Dudley +15 more
2011Molecular Therapy818 citations Open access
Semantic Scholar
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.
Kimberly E. Beck, J. Blansfield, K. Tran, A. Feldman +11 more
2006Journal of Clinical Oncology809 citations Open access
Semantic Scholar
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T cell receptor: Long term follow up and correlates with response
P. Robbins, Sadik H. Kassim, Thai L. Tran, J. Crystal +14 more
2014Clinical Cancer Research736 citations Open access
Semantic Scholar
Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis
J. Yang, M. Hughes, U. Kammula, R. Royal +9 more
2007Journal of immunotherapy704 citations Open access
Semantic Scholar
Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade
Stephanie G. Downey, J. Klapper, F. Smith, J. Yang +11 more
2007Clinical Cancer Research634 citations Open access
Semantic Scholar
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells.
S. Stevanović, Lindsey M. Draper, Michelle M. Langhan, Tracy E. Campbell +9 more
2015Journal of Clinical Oncology607 citations Open access
Semantic Scholar
Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels.
J. Kochenderfer, R. Somerville, Tang-Ying L. Lu, V. Shi +18 more
2017Journal of Clinical Oncology519 citations Open access
Semantic Scholar
Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study
A. Maker, G. Phan, Peter Attia, J. Yang +10 more
2005Annals of Surgical Oncology511 citations Open access
Semantic Scholar
Tumor Progression Can Occur despite the Induction of Very High Levels of Self/Tumor Antigen-Specific CD8+ T Cells in Patients with Melanoma
S. Rosenberg, R. Sherry, K. Morton, William J Scharfman +13 more
2005Journal of Immunology506 citations Open access
Semantic Scholar
CTLA-4 Blockade with Ipilimumab: Long-Term Follow-up of 177 Patients with Metastatic Melanoma
P. Prieto, J. Yang, R. Sherry, M. Hughes +5 more
2012Clinical Cancer Research479 citations Open access
Semantic Scholar
High-dose Interleukin-2 for the Treatment of Metastatic Renal Cell Carcinoma
J. Klapper, Stephanie G. Downey, F. Smith, J. Yang +6 more
2008Cancer442 citations Open access
Semantic Scholar
Tumor Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
Ling Zhang, R. Morgan, J. Beane, Zhi-Li Zheng +14 more
2015Clinical Cancer Research382 citations Open access
Semantic Scholar
Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer.
J. Blansfield, Kimberly E. Beck, K. Tran, J. Yang +8 more
2005Journal of immunotherapy359 citations Open access
Semantic Scholar
Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma.
Stephanie L. Goff, M. Dudley, D. Citrin, R. Somerville +21 more
2016Journal of Clinical Oncology358 citations Open access
Semantic Scholar
Pilot trial of adoptive transfer of chimeric antigen receptor transduced T cells targeting EGFRvIII in patients with glioblastoma
Stephanie L. Goff, R. Morgan, J. Yang, R. Sherry +13 more
2019Journal of immunotherapy338 citations Open access
Semantic Scholar
CD8+ enriched “young” tumor infiltrating lymphocytes can mediate regression of metastatic melanoma
M. Dudley, Colin Gross, Michelle M. Langhan, M. R. Garcia +16 more
2010Clinical Cancer Research317 citations Open access
Semantic Scholar
Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma
A. Maker, J. Yang, R. Sherry, S. Topalian +10 more
2006Journal of immunotherapy273 citations Open access
Semantic Scholar
Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy.
J. Kochenderfer, R. Somerville, Tang-Ying L. Lu, J. Yang +7 more
2017Molecular Therapy265 citations Open access
Semantic Scholar
Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.
Yong-Chen Lu, L. Parker, Tang-Ying L. Lu, Zhi-Li Zheng +13 more
2017Journal of Clinical Oncology253 citations Open access
Semantic Scholar
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.
M. Parkhurst, J. Yang, R. Langan, M. Dudley +15 more
2011Molecular Therapy253 citations Open access
Semantic Scholar
A phase II study of tumor-infiltrating lymphocyte therapy for human papillomavirus-associated epithelial cancers
S. Stevanović, Sarah R. Helman, J. Wunderlich, Michelle M. Langhan +9 more
2018Clinical Cancer Research247 citations Open access
Semantic Scholar
Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines
F. Smith, Stephanie G. Downey, J. Klapper, J. Yang +9 more
2008Clinical Cancer Research242 citations Open access
Semantic Scholar
Treatment of metastatic uveal melanoma with adoptive transfer of tumor infiltrating lymphocytes: a single-center phase 2 study
Smita S. Chandran, R. Somerville, J. Yang, R. Sherry +15 more
2017The Lancet Oncology237 citations Open access
Semantic Scholar
Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.
M. Dudley, Colin Gross, R. Somerville, Young Hong +14 more
2013Journal of Clinical Oncology229 citations Open access
Semantic Scholar
Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy.
Kathryn M. Cappell, R. Sherry, J. Yang, Stephanie L. Goff +4 more
2020Journal of Clinical Oncology225 citations Open access
Semantic Scholar
T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
S. Doran, S. Stevanović, S. Adhikary, Jared J. Gartner +8 more
2019Journal of Clinical Oncology201 citations Open access
Semantic Scholar
Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy
Jenny J. Hong, S. Rosenberg, M. Dudley, J. Yang +3 more
2010Clinical Cancer Research183 citations Open access
Semantic Scholar
Determination of the elimination half-life of fibroblast growth factor-23.
Azarmindokht Khosravi, Carolee M. Cutler, Marilyn H. Kelly, Richard L. Chang +5 more
2007Journal of Clinical Endocrinology and Metabolism153 citations
Semantic Scholar
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes
Nikolaos Zacharakis, Lutfi M. Huq, S. Seitter, Sanghyun P. Kim +22 more
2022Journal of Clinical Oncology150 citations Open access
Semantic Scholar
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
Sanghyun P. Kim, N. Vale, Nikolaos Zacharakis, Sri Krishna +34 more
2022Cancer immunology research141 citations Open access
Semantic Scholar
Tumor Localization and Biochemical Response to Cure in Tumor-Induced Osteomalacia
W. H. Chong, Panagiota Andreopoulou, Clara C. Chen, J. Reynolds +13 more
2013Journal of Bone and Mineral Research139 citations Open access
Semantic Scholar
Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL
Stephanie L. Goff, F. Smith, J. Klapper, R. Sherry +6 more
2010Journal of immunotherapy126 citations Open access
Semantic Scholar
Ocular and Systemic Autoimmunity after Successful Tumor-Infiltrating Lymphocyte Immunotherapy for Recurrent, Metastatic Melanoma
S. Yeh, Neel K Karne, Sid P. Kerkar, Charles Heller +11 more
2009Ophthalmology (Rochester, Minn.)104 citations Open access
Semantic Scholar
Circulating Tumor DNA as an Early Indicator of Response to T-Cell Transfer Immunotherapy in Metastatic Melanoma
Liqiang Xi, T. Pham, Eden C. Payabyab, R. Sherry +2 more
2016Clinical Cancer Research97 citations Open access
Semantic Scholar
Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor Infiltrating Lymphocytes in Patients with Metastatic Melanoma
S. Seitter, R. Sherry, J. Yang, P. Robbins +11 more
2021Clinical Cancer Research90 citations Open access
Semantic Scholar
Outcomes of adoptive cell transfer with tumor-infiltrating lymphocytes for metastatic melanoma patients with and without brain metastases
Gautam U. Mehta, Parisa Malekzadeh, Thomas E. Shelton, D. White +6 more
2018Journal of immunotherapy52 citations Open access
Semantic Scholar
Evaluation of Prime/Boost Regimens Using Recombinant Poxvirus/Tyrosinase Vaccines for the Treatment of Patients with Metastatic Melanoma
Kimberly R. Lindsey, Linda R. Gritz, R. Sherry, A. Abati +13 more
2006Clinical Cancer Research50 citations Open access
Semantic Scholar
Persistence of CTL clones targeting melanocyte differentiation antigens was insufficient to mediate significant melanoma regression in humans
Smita S. Chandran, B. Paria, A. Srivastava, Luke D. Rothermel +8 more
2014Clinical Cancer Research45 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Rosenberg×47
Invite
S. Rosenberg — researcher profile on SciRah
J. Yang×44
Invite
J. Yang — researcher profile on SciRah
U. Kammula×34
Invite
U. Kammula — researcher profile on SciRah
M. Hughes×25
Invite
M. Hughes — researcher profile on SciRah

×21

Invite

M. Dudley — researcher profile on SciRah

Invite

N. Restifo — researcher profile on SciRah

Invite

D. White — researcher profile on SciRah

Invite

R. Royal — researcher profile on SciRah

J. Wunderlich×15

Invite

J. Wunderlich — researcher profile on SciRah

Invite

G. Phan — researcher profile on SciRah

Invite

P. Robbins — researcher profile on SciRah

Invite

S. Feldman — researcher profile on SciRah